The Clorox Company
$ 86.12
-0.42%
05 May - close price
- Market Cap 10,457,278,000 USD
- Current Price $ 86.12
- High / Low $ 86.97 / 84.70
- Stock P/E 14.15
- Book Value -0.55
- EPS 6.11
- Next Earning Report 2026-07-30
- Dividend Per Share $1.24
- Dividend Yield 1.42 %
- Next Dividend Date 2026-05-08
- ROA 0.11 %
- ROE 0.55 %
- 52 Week High 132.95
- 52 Week Low 84.70
About
The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.
Analyst Target Price
$108.24
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-02-03 | 2025-11-03 | 2025-07-31 | 2025-05-05 | 2025-02-03 | 2024-10-30 | 2024-08-01 | 2024-04-30 | 2024-02-01 | 2023-11-01 | 2023-08-02 |
| Reported EPS | 1.64 | 1.39 | 0.85 | 2.87 | 1.45 | 1.55 | 1.86 | 1.82 | 1.71 | 2.16 | 0.49 | 1.67 |
| Estimated EPS | 1.54 | 1.43 | 0.78 | 2.21 | 1.56 | 1.4 | 1.39 | 1.56 | 1.37 | 1.1 | -0.23 | 1.18 |
| Surprise | 0.1 | -0.04 | 0.07 | 0.66 | -0.11 | 0.15 | 0.47 | 0.26 | 0.34 | 1.06 | 0.72 | 0.49 |
| Surprise Percentage | 6.4935% | -2.7972% | 8.9744% | 29.8643% | -7.0513% | 10.7143% | 33.8129% | 16.6667% | 24.8175% | 96.3636% | 313.0435% | 41.5254% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-30 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.66 |
| Currency | USD |
Previous Dividend Records
| May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-05-08 | 2026-02-13 | 2025-11-06 | 2025-08-29 | 2025-05-09 | 2025-02-14 | 2024-11-07 | 2024-08-30 | 2024-05-10 | 2024-02-09 |
| Amount | $1.24 | $1.24 | $1.24 | $1.24 | $1.22 | $1.22 | $1.22 | $1.22 | $1.2 | $1.2 |
Next Dividend Records
| Dividend per share (year): | $1.24 |
| Dividend Yield | 1.42% |
| Next Dividend Date | 2026-05-08 |
| Ex-Dividend Date | 2026-04-22 |
Recent News: CLX
2026-05-05 22:38:10
Clorox (NYSE:CLX) Director Pierre Breber recently purchased 5,000 shares of the company's stock for approximately $429,100, increasing his total stake to 18,000 shares. This insider buying comes as Clorox reported beating quarterly EPS estimates, set FY2026 guidance, and announced a quarterly dividend. Despite the insider purchase, analysts maintain a "Reduce" consensus rating with a target price of $104, reflecting mixed views on the stock.
2026-05-05 21:03:15
Clorox director Pierre R. Breber, through a trust, purchased 5,000 shares of Clorox common stock on the open market at a weighted average price of approximately $85.82 per share. This transaction increased the trust's indirect holdings to 18,000 shares. The purchase occurred in multiple trades ranging from $85.19 to $86.01, indicating a positive sentiment from the insider.
2026-05-05 19:40:17
Clorox (NYSE:CLX) is offering a 5.7% dividend yield, which is significantly higher than the S&P 500 average. However, recent financial results show flat net sales, a 1% organic sales slip, and a projected 6% decline in fiscal 2026 net sales,
2026-05-05 19:37:15
Clorox (NYSE:CLX) currently offers a high 5.7% dividend yield, significantly above the S&P 500 average. However, recent financial results show flat net sales, a 1% organic sales slip, and a projected 6% decline in fiscal 2026 net sales, with diluted EPS potentially dropping 27%, raising concerns about the dividend's sustainability given a potential payout ratio over 100%. Investors are advised to consider safer dividend stocks due to Clorox's severe operational headwinds.
2026-05-05 18:37:15
The Clorox Company (CLX) is down 10.5% after announcing a cut to its full-year 2026 outlook, now expecting a 6% net sales decline and a 24% to 27% drop in diluted EPS, partly due to GOJO acquisition costs and increased investments. The company also filed for potential debt issuance. This revised guidance emphasizes the execution risk associated with cost management and the integration of new assets, impacting the company's investment narrative.
2026-05-05 14:04:19
Jefferies Financial Group reduced its price target for Clorox (NYSE:CLX) from $139 to $125, while maintaining a "buy" rating, indicating a potential 46.9% upside. Despite this, the overall analyst consensus on Clorox is cautious, with a "Reduce" rating and a target price of $104. Clorox recently surpassed Q1 EPS expectations and is trading near its 1-year low, with a market capitalization of $10.3 billion.
